EP 0941330 A1 19990915 - THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING DISEASE STATES WITH MYELOID PROGENITOR INHIBITORY FACTOR-1 (MPIF-1), MONOCYTE COLONY INHIBITORY FACTOR (M-CIF), AND MACROPHAGE INHIBITORY FACTOR-4 (MIP-4)
Title (en)
THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING DISEASE STATES WITH MYELOID PROGENITOR INHIBITORY FACTOR-1 (MPIF-1), MONOCYTE COLONY INHIBITORY FACTOR (M-CIF), AND MACROPHAGE INHIBITORY FACTOR-4 (MIP-4)
Title (de)
THERAPEUTISCHE ZUSAMMENSETZUNGEN UND METHODE ZUR BEHANDLUNG VON KRANKHEITSZUSTÄNDEN MIT EINEM DIE MYELOID-VORLÄUFENZELLEN-HEMMENDEN FAKTOR-1 (MPIF-1), MONOZYTENKOLONIE-HEMMENDEN FAKTOR (M-CIF), UND MAKROPHAGEN-HEMMENDEN FAKTOR 4 (MIP-4)
Title (fr)
COMPOSITIONS THERAPEUTIQUES ET PROCEDES DE TRAITEMENT DE MALADIES UTILISANT LE FACTEUR-1 INHIBITEUR DES PRECURSEURS MYELOIDES (MPIF-1), LE FACTEUR INHIBITEUR DES COLONIES DE MONOCYTES (M-CIF) ET LE FACTEUR-4 INHIBITEUR DE LA MIGRATION DES MACROPHAGES (MIP-4)
Publication
Application
Priority
- US 9717505 W 19970930
- US 2729996 P 19960930
- US 2730096 P 19960930
Abstract (en)
[origin: WO9814582A1] There are disclosed therapeutic compositions and methods using isolated nucleic acid molecules encoding a human myeloid progenitor inhibitory factor-1 (MPIF-1) polypeptide (previously termed MIP-3 and chemokine beta 8 (CK beta 8 or ckb-8)); a human monocyte-colony inhibitory factor (M-CIF) polypeptide (previously termed MIP1- gamma and chemokine beta 1(CK beta 1 or ckb-1)), and a macrophage inhibitory protein-4 (MIP-4), as well as MPIF-1, M-CIF and/or MIP-4 polypeptides themselves, as are vectors, host cells and recombinant methods for producing the same.
IPC 1-7
IPC 8 full level
C12N 15/09 (2006.01); A61K 35/74 (2015.01); A61K 35/76 (2015.01); A61K 38/00 (2006.01); A61K 38/16 (2006.01); A61K 48/00 (2006.01); A61P 1/00 (2006.01); A61P 7/00 (2006.01); A61P 13/12 (2006.01); A61P 17/02 (2006.01); A61P 19/02 (2006.01); A61P 29/00 (2006.01); A61P 43/00 (2006.01); C07K 14/52 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 15/19 (2006.01); C12P 21/02 (2006.01)
CPC (source: EP KR)
A61K 38/16 (2013.01 - KR); A61P 1/00 (2018.01 - EP); A61P 7/00 (2018.01 - EP); A61P 13/12 (2018.01 - EP); A61P 17/02 (2018.01 - EP); A61P 19/02 (2018.01 - EP); A61P 29/00 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07K 14/523 (2013.01 - EP); A61K 38/00 (2013.01 - EP); A61K 48/00 (2013.01 - EP); C12N 2799/026 (2013.01 - EP)
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9814582 A1 19980409; AU 4657697 A 19980424; CA 2267193 A1 19980409; CN 1239510 A 19991222; EP 0941330 A1 19990915; JP 2001500382 A 20010116; KR 20030097607 A 20031231; NZ 335003 A 20001124; NZ 506135 A 20021126
DOCDB simple family (application)
US 9717505 W 19970930; AU 4657697 A 19970930; CA 2267193 A 19970930; CN 97199629 A 19970930; EP 97945352 A 19970930; JP 51675398 A 19970930; KR 20027012833 A 20020927; NZ 33500397 A 19970930; NZ 50613597 A 19970930